GlobeNewswire by notified

ASM ANNOUNCES AGREEMENT TO ACQUIRE LPE, ENTERING HIGH-GROWTH SILICON CARBIDE EPITAXY EQUIPMENT BUSINESS

Share

Almere, The Netherlands
July 18, 2022, 8.00 a.m. CET

ASM International N.V. (Euronext Amsterdam: ASM) today announced that it reached an agreement under which ASM will acquire all outstanding shares of LPE S.p.A., a manufacturer of epitaxial reactors for silicon carbide (SiC) and silicon, based in Italy.

Founded in 1972, LPE has exclusively focused on designing, manufacturing and selling advanced epitaxy tools for power applications. LPE is a recognized leader in SiC epitaxy and has published many patents to date. LPE has a sizeable worldwide installed base of SiC epitaxy tools dedicated to manufacturing devices that address the rapidly growing electric vehicle market. Revenue expectations for LPE in 2023 are greater than €100 million, mainly driven by its SiC epitaxy equipment business.

Silicon carbide devices are experiencing strong growth driven by the rapidly expanding market for electric vehicles. The global auto industry is investing significantly in chips made from silicon carbide. Because of its wide bandgap, SiC is highly efficient at high voltages offering higher power efficiency, increased power density resulting in reduced component weight and size, as well as faster battery charging times. Consequently, demand for SiC epitaxy equipment is forecasted (based on ASM internal estimates) to grow at a CAGR in excess of 25% from 2021 to 2025.

“LPE with its strong culture of innovation and traction with silicon carbide device makers, both for 150mm and 200mm substrates, is well positioned to serve the needs of global automotive customers and their decarbonization drive,” said Benjamin Loh, President and CEO of ASM.
“Next to ASM’s expanding position in advanced Epi applications for the logic/foundry and memory markets, ASM is also a leader in silicon epitaxy solutions for the power electronics, analog and wafer markets. LPE’s offering of advanced SiC epitaxy tools complements ASM’s offering. I’m confident that the combination of LPE and ASM will help our customers accelerate their roadmaps towards next-generation more efficient power electronics, which will enable the further electrification of the automotive industry. The acquisition of LPE adds another high-growth business to our portfolio of differentiated deposition technologies and presents meaningful opportunities to create value by leveraging our innovative epitaxy technologies to further differentiate the product offering of LPE, by building upon our significant customer base in the power electronics market segment, and by utilizing our global field service network to address customer needs.”

Franco Preti, CEO of LPE, said: “We believe the acquisition by ASM will be attractive for LPE’s and ASM’s customers as well as for employees. The acquisition will additionally enable LPE to gain access to world-class R&D resources, as well as leverage on ASM’s global operations, sales and customer support network.”

Following the close of the transaction, LPE will operate as a product unit under ASM’s Global Products organization. LPE will continue to be based in Italy, with technology and manufacturing centers in Milan and Catania. LPE is profitable and is expected to contribute to net earnings immediately after closing.

The transaction is subject to FDI and anti-trust approval in a limited number of countries and other customary closing conditions which are expected to be met by the long stop date of November 10, 2022. Absent a closing by this date, the parties will discuss in good faith on an exclusive basis for a period of six months with the aim to still close the transaction. 

ASM will finance the transaction using a combination of cash and shares. At closing the purchase price will be paid with €283.25 million in cash, and with 631,154 ASM shares. At the date of signing, the payment represents an enterprise value of €425 million on a cash and debt free basis. An additional amount of up to €100 million will be paid by way of an earn out based on certain performance metrics over a two-year period after the closing of the transaction. The shares will be a combination of treasury shares (580,000) and a limited number of newly issued ASM shares (51,154). The earn outs are to be paid out exclusively in cash. The cash amounts will be financed from ASM’s net cash balance.

ASM will further discuss the acquisition in its upcoming Q2 2022 earnings call on July 21, 2022.


About ASM International

ASM International N.V., headquartered in Almere, the Netherlands, and its subsidiaries design and manufacture equipment and process solutions to produce semiconductor devices for wafer processing, and have facilities in the United States, Europe, and Asia. ASM International's common stock trades on the Euronext Amsterdam Stock Exchange (symbol ASM). For more information, visit ASM's website at www.asm.com

Cautionary Note Regarding Forward-Looking Statements: All matters discussed in this press release, except for any historical data, are forward-looking statements. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These include, but are not limited to, economic conditions and trends in the semiconductor industry generally and the timing of the industry cycles specifically, currency fluctuations, corporate transactions, financing and liquidity matters, the success of restructurings, the timing of significant orders, market acceptance of new products, competitive factors, litigation involving intellectual property, shareholders or other issues, commercial and economic disruption due to natural disasters, terrorist activity, armed conflict or political instability, changes in import/export regulations, epidemics and other risks indicated in the Company's reports and financial statements. The Company assumes no obligation nor intends to update or revise any forward-looking statements to reflect future developments or circumstances.

This press release contains inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation.

CONTACT

Investor and media contact:
Victor Bareño
T: +31 88 100 8500
E: investor.relations@asm.com


Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Baltic Horizon Fund consolidated audited results for 202329.3.2024 10:35:00 CET | Press release

Management Board of Northern Horizon Capital AS has approved the audited financial results of Baltic Horizon Fund (the Fund) for the year 2023. The financial results remained unchanged compared to the preliminary disclosure on 15 February 2024. Executing our strategy In a challenging economic landscape characterized by inflation, interest rate volatility, and recent geopolitical events, the Fund has assessed various strategic options to navigate these complexities and ensure future growth. Over the past year, our focus has been on reshaping our strategy to foster sustainable value, concentrating efforts on avenues that promise reliable and consistent growth for our investors. In light of prevailing market conditions, we firmly believe that the execution of the ‘Modern City Life’ strategy, introduced to investors in summer 2023, is paramount to their best interests. In the coming years, we expect two thirds of the Fund’s NOI to come from the centrally located ‘Modern City Life’ multi-fu

Progress on ABN AMRO share buyback programme 22 – 28 March 202429.3.2024 08:00:00 CET | Press release

Progress on ABN AMRO share buyback programme 22 – 28 March 2024 ABN AMRO reports the transaction details related to its EUR 500 million share buyback programme announced on 14 February 2024. During the week of 22 March 2024 up to and including 28 March 2024 a total of 3,000,000 shares and depositary receipts were repurchased at an average price of €15.47 for a total amount of €46,409,760.00. For detailed information on the daily repurchased shares and depositary receipts, individual share purchase transactions and weekly reports, see the ABN AMRO website at https://www.abnamro.com/en/investor-relations/information/share-buyback-programme. To date the total consideration for shares and depositary receipts repurchased amounts to €279,519,000.00 representing 55.9% of the overall share buyback programme. ABN AMRO Press Office pressrelations@nl.abnamro.com +31 20 6288900ABN AMRO Investor Relations investorrelations@nl.abnamro.com +31 20 6282282 This press release is published by ABN AMRO Ba

Public announcement in accordance with article 7:97, §4/1 of the Belgian Companies and Associations Code (“BCAC”) concerning a capital increase by contribution in kind29.3.2024 07:00:00 CET | Press release

Press release Brussels, 29 March 2024 Regulated information – Inside information Public announcement in accordance with article 7:97, §4/1 of the Belgian Companies and Associations Code (“BCAC”) concerning a capital increase by contribution in kind On 20 November 2023, Orange Belgium SA (the “Company”) received notification from Nethys SA (“Nethys”) of its wish to contribute its 25% + 1 shareholding in VOO Holding SA (“VOO”) to the capital of the Company, provided that such contribution results in Nethys holding at least 11% of the Company's share capital (after contribution), pursuant to the provisions of the shareholders' agreement entered into by and between the Company, Atlas Services Belgium SA (“ASB”) and Nethys on 2 June 2023. Nethys can be considered a “related” party to the Company within the meaning of the IAS standards, as it has significant influence over VOO within the meaning of IAS and VOO is part of the group to which the Company belongs. Date and value of the planned t

McWhorter Foundation Combats Nelson Peltz’s Outdated Ideologies and Advocates for Sustainable Inclusivity In Corporate Leadership29.3.2024 06:59:56 CET | Press release

PALM BEACH, Calif., March 29, 2024 (GLOBE NEWSWIRE) -- C.K. McWhorter, chairman of the McWhorter Foundation, voices concerns over outdated perspectives in corporate leadership, exemplified by recent remarks from Nelson Peltz regarding Disney's film direction. After encountering instances of racism and exclusivity on Town of Palm Beach Island (known as home to Jeffrey Epstein, Nelson Peltz and others), McWhorter reflects on the disconnect between elite boardroom discussions and the realities faced by diverse communities. While briefly meeting Nelson Peltz and shaking hands after both departed separate lunches, McWhorter initially respected his insights. However, recent comments made by Peltz suggesting Disney should avoid inclusive films have raised eyebrows and prompted McWhorter to speak out. "It's concerning when influential figures like Peltz advocate against inclusivity in entertainment," McWhorter comments. "The future is in diversity and representation, especially as millennial a

Junshi Biosciences Announces 2023 Full Year Financial Results and Provides Corporate Updates29.3.2024 05:24:27 CET | Press release

SHANGHAI, China, March 29, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial results for the full year of 2023 and provided corporate updates. FINANCIAL HIGHLIGHTS Total revenue was approximately RMB1,503 million during 2023. The revenue from pharmaceutical products increased by approximately 58% compared to 2022. The sales revenue of TUOYI® (toripalimab) was approximately RMB919 million, representing an increase of approximately 25% compared to the previous year.Total research and development (“R&D”) expenses were approximately RMB1,937 million in 2023, representing a decrease of approximately 19% compared to 2022. The decrease in R&D expenses was mainly due to the strategic management of R&D investments in certain early-stage pipelines, while optimizing resource all

HiddenA line styled icon from Orion Icon Library.Eye